Allergan Inc. is a Global Healthcare Company That Develops and Commercializes Specialty Pharmaceutical Products.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c70573) has announced the addition of "Analysis of the Allergan Inc." to their offering. Allergan, Inc. is a global healthcare company that develops and commercializes specialty pharmaceutical products for the ophthalmic, neurological, dermatological dermatological, dermatologic pertaining to dermatology; of or affecting the skin. and other specialty markets. The company operates in specialty pharmaceutical research, targeting products and technologies related to specific disease areas such as glaucoma glaucoma (glôkō`mə), ocular disorder characterized by pressure within the eyeball caused by an excessive amount of aqueous humor (the fluid substance filling the eyeball). , retinal retinal /ret·i·nal/ (ret´i-n'l) 1. pertaining to the retina. 2. the aldehyde of retinol, derived from absorbed dietary carotenoids or esters of retinol and having vitamin A activity. disease, dry eye, psoriasis psoriasis (sôrī`əsĭs), occasionally acute but usually chronic and recurrent inflammation of the skin. The exact cause is unknown, but the disease appears to be an inherited, possibly autoimmune disorder that causes the , acne and movement disorders Movement Disorders Definition Movement disorders are a group of diseases and syndromes affecting the ability to produce and control movement. Description . Allergan also focuses on research and development efforts on new therapeutic areas, including gastroenterology gastroenterology Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833. , neuropathic neuropathic /neu·ro·path·ic/ (-path´ik) pertaining to or characterized by neuropathy. neuropathic pertaining to disease of the nervous system. pain and genitourinary genitourinary /gen·i·to·uri·nary/ (jen?i-to-u´ri-nar-e) pertaining to the genital and urinary organs. gen·i·to·u·ri·nar·y adj. Abbr. diseases. We present Analysis of Allergan Inc. The report includes an overview of the pharmaceutical industry in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , a PEST Framework Analysis of the US Pharmaceutical Industry, and then moves on to analyzing the company itself. Company analysis includes a history of Allergan Inc, a business segment analysis of the segments Allergan operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company's major competitors namely Alcon, Bausch & Lomb, Johnson & Johnson, and Pfizer. A financial analysis of Allergan Inc is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more. A SWOT Framework Analysis of Allergan completes this in-depth company analysis. Contents: A. Executive Summary B. Looking at the Industry B.1 Industry Definition B.2 Brief Profile of the US Pharmaceutical Industry B.3 Impacts on the Industry B.4 Challenges Facing the Industry B.5 Future Perspective C. US Pharmaceutical Industry - PEST Framework Analysis C.1 Political Aspects C.2 Economic Aspects C.3 Social Aspects C.4 Technological Aspects D. Looking at Allergan Inc D.1 Company Profile D.2 History of the Company D.3 Ownership Pattern in the Company D.4 Corporate Hierarchy D.5 Organizational Divisions D.6 Profiling the Key Executives D.7 Products & Services D.8 Corporate Strategies D.9 Recently in the News E. Looking at Business E.1 Business Segments E.2 Geographical Segments E.3 Mergers & Acquisitions Profile E.4 Company Subsidiaries F. Allergan Inc: SWOT Framework Analysis F.1 Strengths to Build Upon F.2 Weaknesses to Overcome F.3 Opportunities to Exploit F.4 Threats to Overcome G. Profiling the Competition G.1 Alcon G.2 Bausch & Lomb G.3 Johnson & Johnson G.4 Pfizer H. Allergan Inc - Financial Analysis H.1 Current Financials H.2 Balance Sheet H.3 Profit & Loss Statement H.4 Ratio Analysis I. AIG: Future Perspective J. Appendix K. Glossary of Terms For more information visit http://www.researchandmarkets.com/reports/c70573 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion